The 4000th eye tumour patient treated with protons at HZB

Overview: Number of patients treated with prontons at HZB from 1998 to 2020.  

Overview: Number of patients treated with prontons at HZB from 1998 to 2020.   © HZB/S. Kodalle

On 19 February 2021, the 4000th eye tumour patient received irradiation with protons, performed by a joint team from Helmholtz-Zentrum Berlin (HZB) and Charité - Universitätsmedizin Berlin. The number of patients treated in 2020 remained at the previous year's level despite the more difficult corona conditions. The treatment in Berlin-Wannsee is only available for uveal melanomas of the eye. The proton accelerator at HZB is the only therapy site for this disease in Germany.

For more than 20 years, Charité - Universitätsmedizin Berlin and Helmholtz-Zentrum Berlin (HZB) have jointly offered irradiation of eye tumours with protons. For this purpose, the HZB operates a proton accelerator, while the medical care of patients is provided by the Charité.

"We congratulate the joint team on this great success and thank them for doing everything they could under the difficult pandemic conditions to maintain the operation of the life-saving eye tumour therapy," says Prof. Bernd Rech, spokesman for the scientific management of HZB. 

500 to 600 people contract malignant uveal melanoma in Germany every year. In 97 percent of cases, the tumour can be completely destroyed by irradiation with protons. In most cases, not only the eye but also the vision can be preserved to a satisfactory degree. Radiation with protons is a particularly effective method: the energy of the proton beam can be adjusted in such a way that practically only the tumour receives the radiation, while the surrounding healthy tissue is spared.


You might also be interested in

  • Humboldt Fellow Alexander Gray comes to HZB
    Humboldt Fellow Alexander Gray comes to HZB
    Alexander Gray from Temple University in Philadelphia, USA, is working with HZB physicist Florian Kronast to investigate novel 2D quantum materials at BESSY II. With the fellowship from the Alexander von Humboldt Foundation, he can now deepen this cooperation. At BESSY II, he wants to further develop depth-resolved X-ray microscopic and spectroscopic methods in order to investigate 2D quantum materials and devices for new information technologies even more thoroughly.
  • Green hydrogen: Nanostructured nickel silicide shines as a catalyst
    Science Highlight
    Green hydrogen: Nanostructured nickel silicide shines as a catalyst
    Electrical energy from wind or sun can be stored as chemical energy in hydrogen, an excellent fuel and energy carrier. The prerequisite for this, however, is efficient electrolysis of water with inexpensive catalysts. For the oxygen evolution reaction at the anode, nanostructured nickel silicide now promises a significant increase in efficiency. This was demonstrated by a group from the HZB, Technical University of Berlin and the Freie Universität Berlin as part of the CatLab research platform with measurements among others at BESSY II.
  • RBB Abendschau on visit at CatLab
    RBB Abendschau on visit at CatLab
    CatLab got a visit from the rbb Abendschau.
    Under the title "Der Weg weg vom Erdgas" (The way away from natural gas), the programme was broadcast on Sunday, 31st July in the rbb Abendschau and will be available in the rbb media library for 7 days.